Hybrid FSP/FSO partnerships offer drug developers a tailored approach to outsourcing clinical trial operations by combining Functional Service Provider (FSP) and Full-Service Outsourcing (FSO) models. These hybrid arrangements enable sponsors to address specific challenges, such as expanding into new regions, scaling resources, or transitioning outsourcing strategies, while maintaining control over critical functions. By integrating PPD FSP solutions into existing or new FSO arrangements, sponsors can optimize clinical trial performance, ensuring efficiency, flexibility, and continuity. This bespoke approach is ideal for managing dynamic trial needs and achieving on-time, on-budget delivery of clinical development projects.

Join for free to read